Lymphocyte subsets predictive value and possible involvement of human papilloma virus infection on breast cancer molecular subtypes

doi:10.5306/wjco.v9.i7.123

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6428)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

386

WORD

223

HTML

3095

Tables (1-4)

257

Sum=3961

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

849

Download

1618

Sum=2467

Nov 10, 2018 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Clin Oncol. Nov 10, 2018; 9(7): 123-132
Published online Nov 10, 2018. doi: 10.5306/wjco.v9.i7.123

Table 1 Demographic characteristics for the breast cancer and benign pathology groups

	Breast cancer (n = 48)	Benign pathology (n = 26)	P value¹
Mean age (yr)	57.79 ± 14.13 (range: 31-85)	32.54 ± 11.63 (range: 14-60)	0.000
Menarche (yr)	12.42 ± 1.67 (range: 9-16)	12.62 ± 1.69 (range: 9-17)	0.763
Term pregnancy	2.63 ± 2.27 (range: 0-11)	1.50 ± 1.55 (range: 0-5)	0.066
Sexual partners	1.98 ± 1.15 (range: 0-5)	1.76 ± 1.09 (range: 1-3)	0.750
Oral contraceptives	47.92%	65.38%	0.352
Tobacco	50.00%	11.53%	0.002
Alcohol	47.92%	46.15%	0.678
Breast cancer family history	37.50%	19.23%	0.199

¹Breast cancer group vs benign pathology group.

Table 2 Mean absolute values for the cellular subsets in the breast cancer and benign pathology groups

	Breast cancer (cel/mm³)	Benign pathology (cel/mm³)	P value¹
TCD3+	1517.95 ± 666.23	1861.68 ± 760.52	0.102
TCD4+	888.73 ± 445.18	974.01 ± 390.17	0.504
TCD8+	551.34 ± 284.35	764.54 ± 431.10	0.048
CD4+/CD8+	1.94 (range: 0.59-6.33)	1.57 (range: 0.64-4.36)	0.271

¹Breast cancer group vs benign pathology group.

Table 3 Correlations between the breast cancer molecular subtypes and the cellular subtypes

	CD4+ (cel/mm³)	CD8+ (cel/mm³)	NK+ (cel/mm³)
Luminal A	916 ± 358.81	645 ± 299.91	1064 ± 455.61
Luminal B HER2-	877 ± 494.16	544 ± 273.04	1120 ± 818.37
Luminal B HER2+	914 ± 318.73	491 ± 208.07	926 ± 500.35
HER2+	680 ± 444.86	426 ± 319.13	834 ± 836.75
TN	992 ± 568.02	483 ± 214.90	1183 ± 837.52
P value¹	0.842	0.527	0.912

¹Between breast cancer molecular subtypes. TN: Triple negative.

Table 4 Correlations between the breast cancer HPV status and the cellular subtypes

	HPV+ (n = 14)	HPV- (n = 34)	P value¹
CD3+ (cel/mm³)	1832.12 ± 537.08	1399.56 ± 665.69	0.563
CD4+ (cel/mm³)	1139.92 ± 416.84	796.56 ± 416.84	0.091
CD8+ (cel/mm³)	630.66 ± 271.00	518.58 ± 281.53	0.748
CD4+/CD8+	2.11 (range: 0.71-4.17)	1.88 (range: 0.59-6.33)	0.029
NK+ (cel/mm³)	1350.21 ± 736.79	950.47 ± 634.35	0.082

¹HPV+ vs HPV-. HPV: Human papilloma virus; NK: Natural killer.

Citation: Fernandes A, Pesci-Feltri A, García-Fleury I, López M, Guida V, De Macedo M, Correnti M. Lymphocyte subsets predictive value and possible involvement of human papilloma virus infection on breast cancer molecular subtypes. World J Clin Oncol 2018; 9(7): 123-132
URL: https://www.wjgnet.com/2218-4333/full/v9/i7/123.htm
DOI: https://dx.doi.org/10.5306/wjco.v9.i7.123